GSK (GSK) – Investing
-
GSK fourth-quarter earnings beat expectations amid strong demand for RSV vaccine
-
European stocks lower; LVMH weighs ahead of Fed rate decision
-
GSK and momelotinib: JPMorgan warns of possible disappointments
-
European stocks drift lower; weak German factory orders hit sentiment
-
European stocks drift lower; weak German factory orders hit sentiment
Back to GSK Stock Lookup